BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 21263136)

  • 1. Muscle histology vs MRI in Duchenne muscular dystrophy.
    Kinali M; Arechavala-Gomeza V; Cirak S; Glover A; Guglieri M; Feng L; Hollingsworth KG; Hunt D; Jungbluth H; Roper HP; Quinlivan RM; Gosalakkal JA; Jayawant S; Nadeau A; Hughes-Carre L; Manzur AY; Mercuri E; Morgan JE; Straub V; Bushby K; Sewry C; Rutherford M; Muntoni F
    Neurology; 2011 Jan; 76(4):346-53. PubMed ID: 21263136
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multi-slice MRI reveals heterogeneity in disease distribution along the length of muscle in Duchenne muscular dystrophy.
    Chrzanowski SM; Baligand C; Willcocks RJ; Deol J; Schmalfuss I; Lott DJ; Daniels MJ; Senesac C; Walter GA; Vandenborne K
    Acta Myol; 2017 Sep; 36(3):151-162. PubMed ID: 29774305
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Local restoration of dystrophin expression with the morpholino oligomer AVI-4658 in Duchenne muscular dystrophy: a single-blind, placebo-controlled, dose-escalation, proof-of-concept study.
    Kinali M; Arechavala-Gomeza V; Feng L; Cirak S; Hunt D; Adkin C; Guglieri M; Ashton E; Abbs S; Nihoyannopoulos P; Garralda ME; Rutherford M; McCulley C; Popplewell L; Graham IR; Dickson G; Wood MJ; Wells DJ; Wilton SD; Kole R; Straub V; Bushby K; Sewry C; Morgan JE; Muntoni F
    Lancet Neurol; 2009 Oct; 8(10):918-28. PubMed ID: 19713152
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lower leg muscle involvement in Duchenne muscular dystrophy: an MR imaging and spectroscopy study.
    Torriani M; Townsend E; Thomas BJ; Bredella MA; Ghomi RH; Tseng BS
    Skeletal Radiol; 2012 Apr; 41(4):437-45. PubMed ID: 21800026
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Magnetic Resonance Assessment of Hypertrophic and Pseudo-Hypertrophic Changes in Lower Leg Muscles of Boys with Duchenne Muscular Dystrophy and Their Relationship to Functional Measurements.
    Vohra RS; Lott D; Mathur S; Senesac C; Deol J; Germain S; Bendixen R; Forbes SC; Sweeney HL; Walter GA; Vandenborne K
    PLoS One; 2015; 10(6):e0128915. PubMed ID: 26103164
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative MRI and strength measurements in the assessment of muscle quality in Duchenne muscular dystrophy.
    Wokke BH; van den Bergen JC; Versluis MJ; Niks EH; Milles J; Webb AG; van Zwet EW; Aartsma-Rus A; Verschuuren JJ; Kan HE
    Neuromuscul Disord; 2014 May; 24(5):409-16. PubMed ID: 24613733
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative proteomic profiling of soleus, extensor digitorum longus, flexor digitorum brevis and interosseus muscles from the mdx mouse model of Duchenne muscular dystrophy.
    Carberry S; Brinkmeier H; Zhang Y; Winkler CK; Ohlendieck K
    Int J Mol Med; 2013 Sep; 32(3):544-56. PubMed ID: 23828267
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Muscle phenotype of a rat model of Duchenne muscular dystrophy.
    Iyer SR; Xu S; Shah SB; Lovering RM
    Muscle Nerve; 2020 Dec; 62(6):757-761. PubMed ID: 32918339
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modeling disease trajectory in Duchenne muscular dystrophy.
    Rooney WD; Berlow YA; Triplett WT; Forbes SC; Willcocks RJ; Wang DJ; Arpan I; Arora H; Senesac C; Lott DJ; Tennekoon G; Finkel R; Russman BS; Finanger EL; Chakraborty S; O'Brien E; Moloney B; Barnard A; Sweeney HL; Daniels MJ; Walter GA; Vandenborne K
    Neurology; 2020 Apr; 94(15):e1622-e1633. PubMed ID: 32184340
    [TBL] [Abstract][Full Text] [Related]  

  • 10. T2 relaxation times are increased in Skeletal muscle of DMD but not BMD patients.
    Wokke BH; Van Den Bergen JC; Hooijmans MT; Verschuuren JJ; Niks EH; Kan HE
    Muscle Nerve; 2016 Jan; 53(1):38-43. PubMed ID: 25847364
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Longitudinal measurements of MRI-T2 in boys with Duchenne muscular dystrophy: effects of age and disease progression.
    Willcocks RJ; Arpan IA; Forbes SC; Lott DJ; Senesac CR; Senesac E; Deol J; Triplett WT; Baligand C; Daniels MJ; Sweeney HL; Walter GA; Vandenborne K
    Neuromuscul Disord; 2014 May; 24(5):393-401. PubMed ID: 24491484
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Postcontractile blood oxygenation level-dependent (BOLD) response in Duchenne muscular dystrophy.
    Lopez C; Taivassalo T; Berru MG; Saavedra A; Rasmussen HC; Batra A; Arora H; Roetzheim AM; Walter GA; Vandenborne K; Forbes SC
    J Appl Physiol (1985); 2021 Jul; 131(1):83-94. PubMed ID: 34013753
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Muscle MRI in Duchenne muscular dystrophy: Evidence of a distinctive pattern.
    Polavarapu K; Manjunath M; Preethish-Kumar V; Sekar D; Vengalil S; Thomas P; Sathyaprabha TN; Bharath RD; Nalini A
    Neuromuscul Disord; 2016 Nov; 26(11):768-774. PubMed ID: 27666775
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Skeletal muscle water T
    Mankodi A; Azzabou N; Bulea T; Reyngoudt H; Shimellis H; Ren Y; Kim E; Fischbeck KH; Carlier PG
    Neuromuscul Disord; 2017 Aug; 27(8):705-714. PubMed ID: 28601553
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alterations in Notch signalling in skeletal muscles from mdx and dko dystrophic mice and patients with Duchenne muscular dystrophy.
    Church JE; Trieu J; Chee A; Naim T; Gehrig SM; Lamon S; Angelini C; Russell AP; Lynch GS
    Exp Physiol; 2014 Apr; 99(4):675-87. PubMed ID: 24443351
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Three-point technique of fat quantification of muscle tissue as a marker of disease progression in Duchenne muscular dystrophy: preliminary study.
    Wren TA; Bluml S; Tseng-Ong L; Gilsanz V
    AJR Am J Roentgenol; 2008 Jan; 190(1):W8-12. PubMed ID: 18094282
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    Gerhalter T; Gast LV; Marty B; Martin J; Trollmann R; Schüssler S; Roemer F; Laun FB; Uder M; Schröder R; Carlier PG; Nagel AM
    J Magn Reson Imaging; 2019 Oct; 50(4):1103-1113. PubMed ID: 30719784
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Longitudinal Evaluation of Muscle Composition Using Magnetic Resonance in 4 Boys With Duchenne Muscular Dystrophy: Case Series.
    Senesac CR; Lott DJ; Forbes SC; Mathur S; Arpan I; Senesac ES; Walter GA; Vandenborne K
    Phys Ther; 2015 Jul; 95(7):978-88. PubMed ID: 25592189
    [TBL] [Abstract][Full Text] [Related]  

  • 19. T₂ mapping provides multiple approaches for the characterization of muscle involvement in neuromuscular diseases: a cross-sectional study of lower leg muscles in 5-15-year-old boys with Duchenne muscular dystrophy.
    Arpan I; Forbes SC; Lott DJ; Senesac CR; Daniels MJ; Triplett WT; Deol JK; Sweeney HL; Walter GA; Vandenborne K
    NMR Biomed; 2013 Mar; 26(3):320-8. PubMed ID: 23044995
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Co-Transplantation of Bone Marrow-MSCs and Myogenic Stem/Progenitor Cells from Adult Donors Improves Muscle Function of Patients with Duchenne Muscular Dystrophy.
    Klimczak A; Zimna A; Malcher A; Kozlowska U; Futoma K; Czarnota J; Kemnitz P; Bryl A; Kurpisz M
    Cells; 2020 Apr; 9(5):. PubMed ID: 32365922
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.